BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

722 related articles for article (PubMed ID: 24299176)

  • 21. Biocatalytic synthesis of intermediates for the synthesis of chiral drug substances.
    Patel RN
    Curr Opin Biotechnol; 2001 Dec; 12(6):587-604. PubMed ID: 11849941
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective synthesis of poly-substituted fluorine-containing pyridines and dihydropyrimidines via cascade C-F bond cleavage protocol.
    Chen Z; Zhu J; Xie H; Li S; Wu Y; Gong Y
    Org Biomol Chem; 2011 Aug; 9(16):5682-91. PubMed ID: 21717032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis, hypoglycaemic, hypolipidemic and PPARγ agonist activities of 5-(2-Alkyl/aryl-6-Arylimidazo[2,1-b][1,3,4]thiadiazol-5-yl)methylene-1,3-thiazolidinediones.
    Khazi MI; Belavagi NS; Kim KR; Gong YD; Khazi IA
    Chem Biol Drug Des; 2013 Aug; 82(2):147-55. PubMed ID: 23581650
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Annual review of new drugs--1973.
    De Haen P
    N Y State J Med; 1973 May; 73(10):1201-5. PubMed ID: 4572539
    [No Abstract]   [Full Text] [Related]  

  • 25. Evolva breeds small molecule drugs au naturel.
    Wolfson W
    Chem Biol; 2009 Jun; 16(6):577-8. PubMed ID: 19549594
    [No Abstract]   [Full Text] [Related]  

  • 26. Synthesis and chemistry of fluorine containing bioactive 1,2,4-triazines--an overview. Chemistry of uncondensed 1,2,4-triazines, Part III.
    Abdel-Rahman RM
    Pharmazie; 1999 Nov; 54(11):791-803. PubMed ID: 10603605
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemical constituents and biological activities of plants from the genus Ligustrum.
    Gao BB; She GM; She DM
    Chem Biodivers; 2013 Jan; 10(1):96-128. PubMed ID: 23341211
    [No Abstract]   [Full Text] [Related]  

  • 28. Fluorine in medicinal chemistry.
    Böhm HJ; Banner D; Bendels S; Kansy M; Kuhn B; Müller K; Obst-Sander U; Stahl M
    Chembiochem; 2004 May; 5(5):637-43. PubMed ID: 15122635
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of 2'-α-fluorine modified nucleoside phosphonates as potential inhibitors of HCV polymerase.
    Parrish JP; Lee SK; Boojamra CG; Hui H; Babusis D; Brown B; Shih IH; Feng JY; Ray AS; Mackman RL
    Bioorg Med Chem Lett; 2013 Jun; 23(11):3354-7. PubMed ID: 23639543
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemical structure does not define obviousness.
    Harrison C
    Nat Rev Drug Discov; 2012 Jun; 11(6):432-3. PubMed ID: 22653206
    [No Abstract]   [Full Text] [Related]  

  • 31. By any other name: ambiguity in marketing proprietary anti-infective agents.
    Berger SA
    Clin Infect Dis; 2007 Jan; 44(1):65-8. PubMed ID: 17143817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Is openness in the drug market possible?].
    Dölle W; Schwabe U
    Internist (Berl); 1986 Jan; 27(1):21-31. PubMed ID: 3514513
    [No Abstract]   [Full Text] [Related]  

  • 33. Practical synthesis of fluorine-containing α- and β-amino acids: recipes from Kiev, Ukraine.
    Kukhar VP; Sorochinsky AE; Soloshonok VA
    Future Med Chem; 2009 Aug; 1(5):793-819. PubMed ID: 21426081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Theoretical studies of the reduction reaction of the anti-tumor drug FR900482.
    Sapse AM; Jain DC
    J Mol Model; 2007 Jan; 13(1):229-32. PubMed ID: 17024411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New drugs and drug products approved in 1997.
    Gage TW
    Tex Dent J; 1998 Sep; 115(9):51-60. PubMed ID: 9807157
    [No Abstract]   [Full Text] [Related]  

  • 36. Complexes of the minor groove of DNA.
    Geierstanger BH; Wemmer DE
    Annu Rev Biophys Biomol Struct; 1995; 24():463-93. PubMed ID: 7663124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adopting orphan drugs: Congress tries to encourage new remedies for rare diseases.
    Wallis C
    Time; 1982 Oct; 120(15):76, 79. PubMed ID: 10317248
    [No Abstract]   [Full Text] [Related]  

  • 38. Large-scale oxidations in the pharmaceutical industry.
    Caron S; Dugger RW; Ruggeri SG; Ragan JA; Ripin DH
    Chem Rev; 2006 Jul; 106(7):2943-89. PubMed ID: 16836305
    [No Abstract]   [Full Text] [Related]  

  • 39. A tough market.
    Ridley-Smith RM
    N Z Med J; 2007 Aug; 120(1260):U2699. PubMed ID: 17726506
    [No Abstract]   [Full Text] [Related]  

  • 40. Fluorinated nucleosides.
    Pankiewicz KW
    Carbohydr Res; 2000 Jul; 327(1-2):87-105. PubMed ID: 10968677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.